Uncategorized

During testing of foreign travellers at Indian airports and ports between December 24 and January 3, eleven COVID-19 variations were found, according to government sources. According to the sources, eleven Omicron sub-variants that had previously been identified as being prevalent in the nation were discovered when testing overseas travellers. International traveller samples totaling 19,227 were analysed, and 124 of those results were positive and isolated, according to the report.
40 of the 124 positive tests had genome sequencing results available, and the largest number of samples with XBB, including XBB.1, was 14. Official sources state that one sample had BF 7.4.1.

According to the Union Ministry of Health and Family Welfare, India recorded a modest increase in COVID infections on Thursday, with 188 new cases reported in the previous 24 hours (MoHFW).
On Wednesday, 175 additional cases were reported nationwide. The MoHFW reports that India now has 2,554 active cases, having an active case rate of 0.01 percent. The nation’s recovery rate, meanwhile, was 98.8% after 201 recoveries occurred on the previous day, bringing the total to 4,41,46,055.

According to the Health Ministry, the nation’s weekly and daily positive rates are 0.12 and 0.10 percent, respectively.
The Health Ministry said that a total of 220.12 crore vaccine doses—95.13 crore second doses and 22.42 crore precaution doses—have been provided as part of the nationwide vaccination campaign against COVID-19, with 61,828 of those doses administered on the previous day. The number of COVID tests performed across the nation increased to 91.15 crores as a result of the 1,93,051 tests that were completed in the past 24 hours, according to the report.

The operational readiness of health institutions is being examined in all states and Union Territories in case of another wave, since there have been reports of an increase in COVID cases in various nations. Covid instances have recently increased globally due to the BF.7 strain, which is thought to be the main source of the increase, particularly in China and the US.

The World Health Organization (WHO) issued an official statement stating that they will continue to closely monitor the situation in the People’s Republic of China and globally and urged all the countries to continue to be vigilant, to monitor and report sequences, as well as to conduct independent and comparative research after reviewing the data, which shows Omicron subvariants BA.5.2 and BF.7 are predominant and account for 97.5 percent of all local infections.
Pre-departure RT-PCR testing is now required for all overseas travellers arriving in India from China, Singapore, Hong Kong, South Korea, Thailand, and Japan.

According to a press statement from the Union Ministry of Health and Family Welfare on January 2, 2023, the test must be completed 72 hours before travelling. The Ministry of Health and Family Welfare has decided to alter its current criteria for international arrivals in light of the growing COVID instances in the aforementioned nations, according to a ministry announcement from Lav Agarwal, assistant secretary, Ministry of Health and Family Welfare.

It stated that the Air Suvidha Portal of the Ministry of Civil Aviation must be made operational for passengers on all international flights from these nations, with a provision allowing international travellers arriving in India to submit both a self-declaration form and negative RT-PCR test reports on this portal.

The number of Covid infections in India slightly increased on Thursday as 188 new cases were reported in the previous 24 hours, according to the Union Ministry of Health and Family Welfare.
On Wednesday, the nation had 175 new cases. The Ministry reports that India now has 2,554 active cases, having an active case rate of 0.01 percent. The nation’s recovery rate, meanwhile, was 98.8% after 201 recoveries occurred on the previous day, bringing the total to 4,41,46,055.

According to the Health Ministry, the nation’s weekly and daily positive rates are 0.12 and 0.10 percent, respectively.
The Health Ministry said that a total of 220.12 crore vaccine doses—95.13 crore second doses and 22.42 crore precaution doses—have been provided as part of the nationwide vaccination campaign against the Covid-19, with 61,828 of those doses administered on the previous day.
The number of Covid tests performed in the nation increased to 91.15 crores as a result of the 1,93,051 tests that were completed in the past 24 hours, according to the report.

The operational readiness of health institutions is being examined in all states and Union Territories in case of another wave, since there have been reports of an increase in Covid cases in various nations.
Covid instances have recently increased globally due to the BF.7 strain, which is thought to be the main source of the increase, particularly in China and the US.

The World Health Organization (WHO) issued an official statement stating that they will continue to closely monitor the situation in the People’s Republic of China and globally and urged all the countries to continue to be vigilant, to monitor and report sequences, as well as to conduct independent and comparative research after reviewing the data, which shows Omicron subvariants BA.5.2 and BF.7 are predominant and account for 97.5 percent of all local infections.
Pre-departure RT-PCR testing is now required for all overseas travellers arriving in India from China, Singapore, Hong Kong, South Korea, Thailand, and Japan.

According to a press statement from the Union Ministry of Health and Family Welfare on January 2, 2023, the test must be completed 72 hours before travelling. The Ministry of Health and Family Welfare has decided to alter its current criteria for international arrivals in light of the growing COVID instances in the aforementioned nations, according to a ministry announcement from Lav Agarwal, assistant secretary, Ministry of Health and Family Welfare.

It stated that the Air Suvidha Portal of the Ministry of Civil Aviation must be made operational for passengers on all international flights from these nations, with a provision allowing international travellers arriving in India to submit both a self-declaration form and negative RT-PCR test reports on this portal.

Potentially dangerous new viruses can spread across the population long before the system for tracking global public health is able to catch them, as the Covid-19 pandemic showed.

But Yale researchers have found that testing nasal swabs for a specific immune system component can assist in identifying covert viruses that are missed by traditional diagnostics, they report on January 3 in the journal Lancet Microbe.

“Finding a dangerous new virus is like searching for a needle in a haystack,” said Ellen Foxman, associate professor of laboratory medicine and immunobiology and senior author of the study, adding, “We found a way to significantly reduce the size of the haystack.”

Public health officials typically look to a few sources for warning signs of emerging disease. They study emerging viruses in animals that may transmit the infection to humans. But determining which of the hundreds, or thousands, of new viral variants, represent a true danger is difficult. And they look for outbreaks of unexplained respiratory ailments, which was how SARS-Cov-2, the virus that causes Covid-19, was discovered in China late in 2019.

By the time an outbreak of a novel virus occurs, however, it may be too late to contain its spread.
For the new study, Foxman and her team revisited an observation in her lab in 2017, which they thought may provide a new way to monitor for unexpected pathogens. Nasal swabs are commonly taken from patients with suspected respiratory infections and are tested to detect specific signatures of 10 to 15 known viruses. Most tests come back negative.

But as Foxman’s team observed in 2017, in a few cases the swabs of those who tested negative for the ‘usual suspect’ viruses still exhibited signs that antiviral defences were activated, indicating the presence of a virus. The telltale sign was a high level of a single antiviral protein made by the cells that line the nasal passages.

Based on that finding, the researchers applied comprehensive genetic sequencing methods to old samples containing the protein and, in one sample, found an unexpected influenza virus, called influenza C.

The researchers also used this same strategy of retesting old samples to search for missed cases of Covid-19 during the first two weeks of March 2020. While cases of the virus had surfaced in New York State around that same time, testing was not readily available until weeks later. Hundreds of nasal swab samples collected from patients at Yale-New Haven Hospital during that time had tested negative for standard signature viruses. When tested for the immune system biomarker, the vast majority of those samples showed no trace of activity of the antiviral defence system. But a few did; among those, the team found four cases of Covid-19 that had gone undiagnosed at the time.

The findings reveal that testing for an antiviral protein made by the body, even if the tests for known respiratory viruses are negative, can help pinpoint which nasal swabs are more likely to contain unexpected viruses.

Researchers may be able to focus their search for unexpected pathogens by screening for the biomarker, which makes it possible to conduct surveillance for unexpected viruses using swabs obtained during standard patient treatment. In order to uncover unexpected or emergent pathogens circulating in the patient population and to prompt a response from the medical community, samples found to have the biomarker can be evaluated using more sophisticated genetic testing techniques.

Lung function depends on the right balance of specialised epithelial cells, which cover the body’s surfaces and coordinate biological functions to maintain homeostasis. One important kind of lung cell is the goblet cell, which secretes mucus to protect the lining of the bronchus (the main air tubes of the lung) and trap bacteria. Although it is unknown what signals lead to this imbalance, goblet cells are typically increased in lung illnesses.
Researchers have recently identified a fresh set of signals that regulate the generation of goblet cells in the lung, according a study published in the journal “Cell Reports.”

According to corresponding author Bob (Xaralabos) Varelas, PhD, associate professor of biochemistry at Boston University School of Medicine, “by changing the proteins that control these signals we are able to either increase or decrease the production of goblet cells, offering potential new avenues for therapeutically targeting goblet cells in lung disease.” The scientists employed an experimental model with genetic deletions in the Yap and Taz genes, which produce proteins that regulate a crucial signalling network in the lung. When they compared the genetic deletion model to a “control” animal, they discovered that the Yap/Taz deletion model had significantly worse lung damage and a higher number of goblet cells, which were linked to higher mucin production.

The researchers extracted cells from the experimental model and human lungs and grew them in the lab to better understand how loss of Yap/Taz resulted in elevated goblet cell counts. They next utilised investigations of chromatin binding and gene expression to determine how these proteins regulate a network of genes crucial for mucus formation. Finally, they tested goblet cell differentiation and mucus production inhibitors in the lab using these cells.
The researchers claim that a number of lung conditions, including asthma, COPD, cystic fibrosis, and chronic bronchitis, show an enlargement of goblet cells.

“By discovering novel regulators of goblet cell formation, we provide insight into potential processes underlying these disorders. We can stop the creation and upkeep of tumours by focusing on these signals. “By identifying new regulators of goblet cell production, we offer insight into mechanisms that may contribute to these diseases. By targeting these signals we can repress the production and maintenance of goblet cells and therefore may offer therapeutic directions for limiting the expansion of these cells in lung disease,” said Varelas.

When things get too much, we usually hear the advice to “take a burden off,” but when it comes to bone care, the reverse can be helpful. Japanese researchers have discovered several crucial mechanisms for how physical tension triggers bone growth.
In a study that was published in the journal “Cell Reports,” researchers from the National Cerebral and Cardiovascular Center Research Institute demonstrated how load influences the production of the peptide osteocrin (OSTN), which increases when stress is applied and reduces when it is decreased. Exercise loads build bones and skeletal muscles, avoiding bone and muscle atrophy. Maintaining bone and muscle strength is crucial for continuing to engage in physical activity.

Long bones like the femur and tibia grow through a very intricate process that is influenced by both genetics and environmental elements like exercise and gravity.

“Not much is known about how mechanical force initiates biochemical signals to control bone growth,” says lead author of the study Haruko Watanabe-Takano. “We investigated how load is related to the metabolic balance adjustment of bone maintenance.”

Osteoblasts, which form bone, and osteoclasts, which break it down, function in harmony to maintain bone, which is assumed to be created in response to load requirement. The group specifically looked at OSTN, an osteoblast-produced peptide, and its expression in mice. Both the control of bone development and athletic endurance depend on OSTN.
The area where the load was applied and in bones like the tibia, radius, and ulna were where the researchers discovered that OSTN was highly expressed.

Furthermore, they demonstrated that the periosteal osteoblasts in these bones secreted OSTN. The periosteum, a membrane that covers the outside of bones except where long bones connect, plays a role in bone creation and remodelling, particularly during growth.

“We also found that OSTN expression decreased when load was reduced, and was increased by load stimulation,” says Watanabe-Takano. “Moreover, when we genetically engineered mice lacking OSTN, we found that they had reduced bone mass compared with normal mice and lacked load-induced recovery of bone mass after prolonged load reduction. Thus, we concluded that OSTN makes bone in response to stimulation by load, promoting bone formation.”

The scientists discovered that OSTN raises levels of another peptide termed C natriuretic peptide, which in turn stimulates bone-forming osteoblasts to proliferate, mature, and develop into functional cells. Given that prolonged bed rest is known to limit bone production, the findings of this study will be helpful in promoting bone preservation in bedridden patients as well as in the prevention and management of frailty syndrome. Future studies will build on these results to discover further mechanisms, such as how periosteal cells detect load stimulation.